Literature DB >> 9806120

Liver cirrhosis and the risk of primary liver cancer.

C La Vecchia1, E Negri, L Cavalieri d'Oro, S Franceschi.   

Abstract

The relationship between liver cirrhosis and hepatocellular carcinoma is recognized, but quantification of risk is still uncertain. Therefore, we analysed data from a case-control study conducted in Italy between 1984 and 1997 on 499 cases of incident, histologically confirmed hepatocellular carcinoma and 1,552 controls in hospital with acute, non-neoplastic disease. Overall, 87 (17.4%) cases vs 10 (0.6%) controls reported clinical history of liver cirrhosis. The corresponding odds ratio (OR) was 27.5 (95% confidence interval (CI), 14.3-15.2) after allowance for sociodemographic factors, and 16.2 (95% CI, 7.9-32.9) after simultaneous allowance for all identified confounding factors, including alcohol consumption and clinical history of hepatitis. The association was of similar magnitude for subjects whose cirrhosis was diagnosed < 55 years (OR = 14.8) or at age 55 or over (OR = 20.0), and the multivariate OR was 33.7 < 5 years after diagnosis of cirrhosis, 37.3 between 5 and 9 years, and 7.6 (95% to 2.7-21.3) > or = 10 years since diagnosis of cirrhosis. The association was stronger in males (OR = 23.4) than in females (OR = 5.9), similar in various age groups, and somewhat stronger in more educated subjects (OR = 53.7), with history of hepatitis (OR = 33.1), reporting heavy alcohol consumption (OR = 24.9) or high body mass index (OR = 58.1), although the interaction term was significant only for sex. In terms of population attributable risk, 17% of hepatocellular carcinomas in this population can be attributed to clinical history of liver cirrhosis.

Entities:  

Mesh:

Year:  1998        PMID: 9806120     DOI: 10.1097/00008469-199808000-00007

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  17 in total

Review 1.  Decorin-TGFβ axis in hepatic fibrosis and cirrhosis.

Authors:  Kornélia Baghy; Renato V Iozzo; Ilona Kovalszky
Journal:  J Histochem Cytochem       Date:  2012-01-19       Impact factor: 2.479

Review 2.  Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.

Authors:  R Ranjha; J Paul
Journal:  Inflamm Res       Date:  2013-02-17       Impact factor: 4.575

3.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

4.  Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice.

Authors:  Kornélia Baghy; Katalin Dezso; Viktória László; Alexandra Fullár; Bálint Péterfia; Sándor Paku; Péter Nagy; Zsuzsa Schaff; Renato V Iozzo; Ilona Kovalszky
Journal:  Lab Invest       Date:  2010-10-18       Impact factor: 5.662

Review 5.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

6.  Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center.

Authors:  Ana Lleo; Francesca Colapietro; Patrick Maisonneuve; Monia Aloise; Vincenzo Craviotto; Roberto Ceriani; Lorenza Rimassa; Salvatore Badalamenti; Matteo Donadon; Vittorio Pedicini; Alessandro Repici; Luca Di Tommaso; Antonio Voza; Guido Torzilli; Alessio Aghemo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

7.  Coffee consumption and risk of cancers: a meta-analysis of cohort studies.

Authors:  Xiaofeng Yu; Zhijun Bao; Jian Zou; Jie Dong
Journal:  BMC Cancer       Date:  2011-03-15       Impact factor: 4.430

8.  Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study.

Authors:  Hung N Luu; Jaideep Behari; George Boon-Bee Goh; Renwei Wang; Aizhen Jin; Claire E Thomas; Jose C Clemente; Andrew O Odegaard; Woon-Puay Koh; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-13       Impact factor: 4.090

9.  A meta-analysis of alcohol drinking and cancer risk.

Authors:  V Bagnardi; M Blangiardo; C La Vecchia; G Corrao
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

10.  Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan.

Authors:  Y Kurozawa; I Ogimoto; A Shibata; T Nose; T Yoshimura; H Suzuki; R Sakata; Y Fujita; S Ichikawa; N Iwai; A Tamakoshi
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.